The toxins could potentially be used as ‘markers’ for doctors to identify Parkinson’s patients at a higher risk of developing ...
A study has found a previously known cancer-related drug can also help slow down the symptoms of Parkinson's disease, but human testing is yet to begin.
If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...
Every 27 minutes, someone in Australia is diagnosed with Parkinson's disease. Best known for its tremors, movement and ...
A test that can detect Parkinson's disease in the early stages of the illness has moved a step closer. Scientists have developed a way of detecting a molecule linked to the condition in samples of ...
The world's largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments that can slow or halt ...
Researchers have finally seen and measured the tiny alpha-synuclein oligomers that may ignite Parkinson’s disease. With the ...
TipRanks on MSN
Regeneron’s New Parkinson’s Study: A Potential Game-Changer?
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals is conducting a ...
Lucknow: Doctors at RMLIMS have successfully performed the institute's first deep brain stimulation (DBS) surgery on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results